#USA #Orlando #Clinical Trials #SCOPE Summit #TransCelerate

Transforming Clinical Trials: TransCelerate at SCOPE US 2026

TransCelerate BioPharma, a nonprofit organization committed to enhancing health across the globe, will showcase its impactful strategies for making clinical trials more effective and patient-focused at the highly anticipated SCOPE Summit 2026. This annual event, scheduled for February 2-5 in Orlando, Florida, gathers leaders from the biopharmaceutical sector, regulatory bodies, and clinical research communities to discuss innovative solutions in trial design and execution.

As clinical trials evolve, they are becoming increasingly intricate while demands for expedited results and high-quality outcomes continue to rise. Rob DiCicco, Vice President of Portfolio Management at TransCelerate, emphasizes the urgency of addressing these challenges through collective efforts. According to him, “No single organization can solve these challenges alone. At SCOPE, we’re focusing on practical, collaborative approaches that reduce the burden on clinical sites and participants, thereby enhancing the usability of data.” This year's presentation will encompass seven sessions aimed at modernizing clinical trial operations, supported by insights from renowned partner companies, including Amgen, Merck, and Pfizer.

Key Sessions to Attend

1. Enabling Research at the Point of Care
Date & Time: February 3, 2026, at 11:05 a.m. ET
Speakers: Kevin Bugin (Amgen), Rob DiCicco (TransCelerate)
This session will delve into collaborative efforts to promote high-quality data generation at the point of care, involving patients, healthcare providers, regulators, and life sciences companies.

2. Optimizing Protocol Data Collection
Date & Time: February 3, 2026, at 3:05 p.m. ET
Speakers: Laura Galuchie (Merck), Ken Getz (Tufts University)
Explore findings from a collaborative study that investigates how increasing protocol data complexity contributes to participant burdens during trials.

3. Implementation of Digital Protocols
Date & Time: February 3, 2026, at 3:30 p.m. ET
Speakers: Chris Decker (CDISC), Rob DiCicco
Learn how digital protocol standards facilitate automation and enhance the efficiency of trial execution.

4. From Tabletop To Trial
Date & Time: February 4, 2026, at 9:00 a.m. ET
Speakers: Meghana Chalasani (FDA), Zhanna Jumadilova (Pfizer), Stacy Tegan (TransCelerate)
This discussion will offer insights from tabletop exercises aimed at integrating pragmatic elements into trials for better point-of-care research.

5. Yes, You Can (Digitalize That)
Date & Time: February 5, 2026, at 8:35 a.m. ET
Speakers: William Illis (Novartis), Donald Jennings (Eli Lilly)
* The focus will be on how the digitalization of protocol designs minimizes manual workload and speeds up study start-up processes.

These sessions underscore TransCelerate's commitment to facilitating streamlined trial designs that significantly benefit patients while addressing the complexities inherent in modern clinical research.

Meet TransCelerate at SCOPE

Media representatives who wish to meet with TransCelerate at the SCOPE Summit are encouraged to reach out to Hannah Davis at [email protected] to schedule an appointment.

In summary, TransCelerate BioPharma is poised to make a substantial impact on the clinical trial landscape at SCOPE Summit 2026. By harnessing collaborative approaches and leveraging technology, they aim to enhance the research lifecycle, providing more effective solutions for clinical trials that are imperative for patient health worldwide.

For further insights, visit TransCelerate's official website.